Amneal Completes Kashiv Takeover

Bolsters Capabilities In Complex Generics And 505(b)(2) Hybrid Drugs

 
• By Dave Wallace

Amneal says it has taken the latest step towards “Amneal 2.0” after completing its deal to acquire Kashiv Specialty Pharmaceuticals.

2.0 Wireframe
The deal is the latest step towards “Amneal 2.0” • Source: Shutterstock

More from Deals

More from Business